The participants were randomly divided into RA (n=25) or SLE (n=7) and were prescribed HCQ (Plaquenil®) 200 mg daily for 8 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback